With a national pharmacare program potentially on the horizon, many plan sponsors will be wondering about the impact on their benefits plans. At Benefits Canada‘s Calgary Benefits Summit on May 29, Joe Farago, executive director of health-care innovation at Innovative Medicines Canada, discussed some of the implications of national pharmacare. Farago began his session by […]
Despite not yet announcing its election platform, Ontario’s Progressive Conservative Party may have the greatest potential for affecting pensions and benefits in Ontario. “The Conservatives’ broad focus on balancing the budget, which may result in their rationalizing OHIP and delisting some services, represents the real impact potential in this election,” says Anneliesje Warner, a health […]
Insurance companies expect health costs to rise by 11.8 per cent this year, according to an annual survey by Accompass Inc. The survey determines the anticipated year-over-year cost increase or decrease — or health trend factor — by asking insurers to examine their businesses and take various factors into account, including legislation, claims utilization, inflation, fee increases […]
With governments having announced a number of changes related to pharmaceutical policy, plan sponsors are facing a shifting environment for their drug plans. “There are a lot of things happening today in the world of pharmaceuticals, drug plans, benefit plans, pricing, reimbursement and access to drugs,” said Wayne Critchley, senior associate for the health and […]
With a number of government reforms and new policies in the works, plan sponsors may well wonder about the potential impact on private drug plans. With that in mind, Suzanne Lepage, a private health plan strategist, led a panel discussion on new government policies and programs in the works at the Face to Face Drug […]
It’s not often that the issues relevant to benefits plans emerge as an area of focus in the political realm. But with votes up for grabs and politicians eager to find any way to harness them, it appears issues of drugs and dental care are moving up the political agenda. In the federal arena, the […]
In last week’s report on pharmacare, the House of Commons’ standing committee on health recommended a significant departure from the current mix of private drug coverage supplemented by public programs. While the report referenced various provincial drug programs that supplement private benefits plans or cover those without their own insurance — including those offered by Quebec, […]
The House of Commons’ standing committee on health is recommending the creation of a universal, single public payer prescription drug coverage program for all Canadians. “The committee believes that the best approach for the creation of such a program is through the expansion of the Canada Health Act to include prescription drugs dispensed outside of hospitals as an insured service,” […]
The number of Ontarians using the Trillium drug program increased threefold between the beginning of 2000 and the end of 2016, according to a new study published in the Canadian Medical Association Journal. Between 2000 and 2015, the number of overall Trillium recipients increased 176,299 from 55,571. During the same time frame, the proportion of plan beneficiaries […]
Ontario’s political parties are busy making promises about key benefits issues as they prepare for this June’s election campaign, with the governing Liberals announcing a plan expand the OHIP+ pharmacare program to seniors and the New Democratic Party proposing action on dental care. On Tuesday, just days after the Ontario NDP pledged universal pharmacare and dental coverage should […]